Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00983112Phase 4Unknown
Phase 4, randomised, single-blind trial in hemorrhage comparing Evicel with Placebo (2 arms). Primary endpoint: Bleeding loss at Day 5. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00983112.